Your browser doesn't support javascript.
loading
Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review.
Bonten, Marc; Johnson, James R; van den Biggelaar, Anita H J; Georgalis, Leonidas; Geurtsen, Jeroen; de Palacios, Patricia Ibarra; Gravenstein, Stefan; Verstraeten, Thomas; Hermans, Peter; Poolman, Jan T.
Afiliação
  • Bonten M; Julius Center, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Johnson JR; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • van den Biggelaar AHJ; P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium.
  • Georgalis L; P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium.
  • Geurtsen J; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
  • de Palacios PI; Clinical Development, Janssen Vaccines, Bern, Switzerland.
  • Gravenstein S; Brown University and Providence Veterans Administration Hospital, Providence, Rhode Island, USA.
  • Verstraeten T; P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium.
  • Hermans P; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
  • Poolman JT; Bacterial Vaccines Discovery and Early Development, Janssen Vaccines and Prevention B.V., Leiden, The Netherlands.
Clin Infect Dis ; 72(7): 1211-1219, 2021 04 08.
Article em En | MEDLINE | ID: mdl-32406495
ABSTRACT

BACKGROUND:

Escherichia coli is the most common cause of bacteremia in high-income countries. To enable the development and implementation of effective prevention strategies, a better understanding of the current epidemiology of invasive E. coli infections is needed.

METHODS:

A systematic review of literature published between 1 January 2007 and 31 March 2018 on the burden and epidemiology of E. coli bacteremia in populations that include adults in high-income countries was conducted. Meta-analysis was performed for descriptive purposes.

RESULTS:

During the studied time interval, the estimated incidence rate of E. coli bacteremia was 48 per 100 000 person-years, but this increased considerably with age rates per 100 000 person-years were >100 in 55-to-75-year-olds and >300 in 75-to-85-year-olds. Overall, E. coli accounted for 27% of documented bacteremia episodes 18% if hospital acquired, 32% if community-onset healthcare associated, and 33% if community acquired. The estimated case fatality rate was 12%. Approximately 44% of episodes were community acquired, 27% community-onset healthcare associated, and 27% hospital acquired. Urinary tract infection (UTI) was the primary source for 53% of episodes.

CONCLUSIONS:

This systematic review confirms the substantial burden of E. coli bacteremia in older adults and justifies the implementation of community-level programs to prevent E. coli bacteremia and ideally UTI in this age group.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Urinárias / Bacteriemia / Infecções Comunitárias Adquiridas / Infecções por Escherichia coli Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Urinárias / Bacteriemia / Infecções Comunitárias Adquiridas / Infecções por Escherichia coli Idioma: En Ano de publicação: 2021 Tipo de documento: Article